Amaba, Estrella .

HRN: 24-77-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/31/2024
04/07/2024
IV
1.5g
Q6hours
CAP-MR
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes